SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-251869
Filing Date
2020-09-23
Accepted
2020-09-23 09:09:01
Documents
11
Period of Report
2020-09-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d33410d8k.htm   iXBRL 8-K 22291
2 EX-99.1 d33410dex991.htm EX-99.1 43450
  Complete submission text file 0001193125-20-251869.txt   180448

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ck0000711377-20200922.xsd EX-101.SCH 3087
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0000711377-20200922_lab.xml EX-101.LAB 15318
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0000711377-20200922_pre.xml EX-101.PRE 9669
6 EXTRACTED XBRL INSTANCE DOCUMENT d33410d8k_htm.xml XML 2992
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 201191060
SIC: 2835 In Vitro & In Vivo Diagnostic Substances